SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-13-416220
Filing Date
2013-10-29
Accepted
2013-10-29 17:30:59
Documents
2
Period of Report
2013-10-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d619105d6k.htm 6-K 8874
2 EX-99.1 d619105dex991.htm EX-99.1 221121
  Complete submission text file 0001193125-13-416220.txt   231001
Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3
Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 131177257
SIC: 2834 Pharmaceutical Preparations